Cite this article
4
Downloads
2
Citations
29
Views
Announcements
Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Original Research
Single uroflow study as a tool in predicting the possibility of abnormal voiding symptoms after the administration of antimuscarinic agents in treating overactive bladder syndrome
Show Less
1
Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei
2
Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Keelung, Keelung
3
Department of Management Information Systems, National Chung Hsing University, Taichung
4
Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan (Taiwan)
Clin. Exp. Obstet. Gynecol. 2015, 42(2), 152–155;
https://doi.org/10.12891/ceog1799.2015
Published: 10 April 2015
Abstract
Purpose of study: The aim of this study was to evaluate the efficacy of uroflowmetry in predicting the possibility of abnormal voiding symptoms following antimuscarinic treatment for overactive bladder syndrome (OAB) in Taiwanese women. Materials and Methods: A retrospective study was conducted on women with OAB. Forty-five women with abnormal voiding patterns shown by urodynamic study comprised the main group and 38 women with normal voiding patterns comprised the control group. All patients were prescribed two mg tolterodine once daily for one week. Follow-up on complaints of abnormal voiding symptoms was done one week later. Results: One woman in control group and 12 women in main group complained of abnormal voiding symptoms. There was a significant difference in the occurrence of abnormal voiding symptoms after antimuscarinic administration between main study group and control group (26.7 % vs 2.6 %, p = 0.02). Conclusion: Uroflowmetry is a non-invasive and simple tool to predict the occurrence of abnormal voiding symptoms after antimuscarinic use.
Keywords
Overactive bladder
Antimuscarinics
Urodynamics
Voiding pattern
Uroflowmetry